NCT03279263View on ClinicalTrials.gov

An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy

PHASE2UnknownINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

MLR-1023

MLR-1023 Tablets

OTHER

Placebo

Matching Placebo Tablets

Trial Locations (1)

90057

National Research Institute, Los Angeles

Sponsors
All Listed Sponsors
collaborator

Bukwang Pharmaceutical, Co., Ltd.

INDUSTRY

lead

Melior Pharmaceuticals

OTHER